European prazosin market is estimated to decline during the forecast period. Additionally, according to the IHME (Institute for Health Metrics and Evaluation), in Western Europe, there was 3.92% share of the total population that was suffering from depression, 5.71% of the total population had an anxiety disorder and 0.94 % share of the population had bipolar disorder in 2017. Since one of the major applications of prazosin is for curing nightmare. Hence, the population suffering from some form of mental disorders is required prazosin. However, there are several side effects associated with these drugs, in which some of them are negligible; yet there are some severe side effects that are restraining the growth of the market. Some of the severe side effects associated with the use of prazosin include headache, drowsiness, tiredness, weakness, blurred vision, nausea, vomiting, diarrhea, or constipation may occur as the body adjusts to the medication.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/european-prazosin-market
The European prazosin market is segmented on the basis of application. Based on the application, the market is segmented into cardiovascular disease, neurological syndromes, prostate disorders, and kidney disorders. The CVD segment accounted for a significant share in the European prazosin market. CVDs claim to take more lives each year than all forms of cancer and chronic lower respiratory diseases altogether. Thus, Prazosin is one of the treatments used for CVD mainly high BP and strokes. For instance, Minipress is specified for the treatment of hypertension, to control BP. Lowering blood pressure decreases the risk of fatal and nonfatal cardiovascular events, mainly strokes and myocardial infarction.
The companies which are contributing to the growth of the European prazosin market include Axon Medchem LLC, Merck KGaA, Mylan N.V., Pfizer Inc., and others. The market players are considerably contributing to the market growth by adopting various strategies including new product launch, merger, and acquisition, collaborations to stay competitive in the market.
European Prazosin Market- Segmentation
By Application
- Cardiovascular Disease(CVD)
- Neurological Syndromes
- Prostate Disorders
- Kidney Disorders
A full report of European Prazosin Market is available at: https://www.omrglobal.com/industry-reports/european-prazosin-market
European Prazosin Market– Segment by Region
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
